Thats not where the risk-benefit lies. Given that health insurance wont cover GLP-1s if you arent obese, dont have type 2 diabetes, or arent overweight with cardiovascular disease, the cost can add up for years before you know whether the spend was really worth it
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed in the UK for type 2 diabetes management and, more recently, for weight management in adults with obesity
Is the treatment safe for this person
Itll change your life, just like it did mine! Thomas Fitzpatrick, 29 years old, Portland, USA Ive struggled with insecurity and discomfort due to swollen lymph nodes on my neck for as long as I can remember, and its caused me a lot of distress in life
TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
Details of individual studies are registered on ClinicalTrials.gov and the EU Clinical Trials Register